Clinical Trial Update: A Phase III Study to Assess the Effect of AZD0780 on LDL-C in Patients With Clinical ASCVD or at Risk for a First ASCVD Event [Phase 3]

View source ↗

Summary

Phase III clinical trial update for AZD0780 evaluating its effect on LDL cholesterol in patients with atherosclerotic cardiovascular disease or at risk for a fi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerotic Cardiovascular Disease
• Cardiovascular Disease

Drugs mentioned

• AZD0780

Snippet

Sponsor: AstraZeneca | Conditions: Cardiovascular Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING